Copelink Blog

CancerCare is pleased to welcome Teresa Bitetti, Senior Vice President of US Oncology at Bristol-Myers Squibb, to its Board of Trustees.

“We are honored that Bristol-Myers Squibb has chosen Teresa to serve on the CancerCare Board of Trustees. Having such a talented senior executive volunteer her time and expertise to CancerCare, is yet another example of Bristol-Myers Squibb’s commitment to patients,” said Patricia J. Goldsmith, CEO of CancerCare.

In her current role at Bristol-Myers Squibb, Bitetti leads the strategy and commercial operations for the US Oncology organization. Prior to this appointment, she served as President and General Manager of Bristol-Myers Squibb Canada where she was responsible for commercial operations across the entire portfolio. Bitetti joined Bristol-Myers Squibb in 1996, and she has successfully led teams across therapeutic areas and functions. Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

“Teresa’s understanding of the impact of cancer and her diverse experience in finance, strategic planning and marketing will undoubtedly add valuable insight to our organization’s leadership,” said Michael Parisi, President of the CancerCare Board of Trustees. “We are excited to work with her to further CancerCare’s mission of providing emotional support and financial assistance to anyone affected by cancer.”

“I am honored to be selected to serve on CancerCare’s Board of Trustees. From both a personal and professional perspective, I understand how important it is for people fighting cancer to receive comprehensive, personalized care,” said Teresa Bitetti “CancerCare has a longstanding tradition of providing a unique model of services to the cancer community and I look forward to contributing to their continued success.”

Prior to joining Bristol-Myers Squibb, Bitetti held various roles of increasing responsibility at Mobil Oil Corporation where she was part of the Capital Markets Group and was responsible for the investment of Mobil's worldwide pension assets. Bitetti holds a BA in Classical Civilization and an MBA in Finance.

Bitetti is joined by 28 fellow Board Members who provide fiscal and strategic oversight of the national nonprofit. Their leadership plays a pivotal role in allowing the organization to directly serve more than 170,000 people affected by cancer across the nation each year.